Insider Transactions in Q1 2021 at Odonate Therapeutics, Inc. (ODTC)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2021
|
Joseph P O'Connell Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
99
+2.67%
|
$1,584
$16.22 P/Share
|
|
Mar 15
2021
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37
+1.39%
|
$592
$16.22 P/Share
|
|
Feb 26
2021
|
Joseph P O'Connell Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
90
+2.5%
|
$1,530
$17.89 P/Share
|
|
Feb 26
2021
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
34
+1.3%
|
$578
$17.89 P/Share
|
|
Feb 12
2021
|
Joseph P O'Connell Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
76
+2.17%
|
$1,596
$21.19 P/Share
|
|
Feb 12
2021
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28
+1.09%
|
$588
$21.19 P/Share
|
|
Jan 29
2021
|
Joseph P O'Connell Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
82
+2.39%
|
$1,558
$19.64 P/Share
|
|
Jan 29
2021
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31
+1.21%
|
$589
$19.64 P/Share
|
|
Jan 15
2021
|
Joseph P O'Connell Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
94
+2.8%
|
$1,504
$16.99 P/Share
|
|
Jan 15
2021
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35
+1.39%
|
$560
$16.99 P/Share
|